Cutaneous Oncology News

DermTech has reported that the AMA has granted the company category 1, tier 2 molecular pathology procedure codes related to its proprietary test for the detection of melanoma-related gene expression.

African-Americans with mycosis fungoides experienced poorer overall survival than white or Asian patients, according to recent findings.

Google search volume correlated with state-specific cancer incidence and mortality rates for melanoma and other common cancers, according to recently published study results in JAMA Dermatology.

Study findings that pathologists had lower levels of accuracy and reproducibility in diagnosing some melanomas when compared with other types of melanoma was among recent developments reported on Healio.com/Dermatology.

Research showing that nail findings distinguished patients with psoriatic arthritis from those with psoriasis without arthritis was among the top read articles of the past week on Healio.com/Dermatology.

Anatomic location and subtotal diagnostic biopsies were the greatest risk factor for upstaging of melanoma, according to recently published study results in the Journal of the American Academy of Dermatology.

Nivolumab prolonged RFS compared with ipilimumab among patients with advanced melanoma who had undergone resection, according to an interim analysis of a randomized phase 3 trial.

La Roche-Posay recently announced the launch of the third edition of its Become A Skin Checker campaign.

Patients with Parkinson disease or melanoma each had increased risk for the other disease, according to results of a retrospective cohort study.

The FDA cleared the expanded use of the DigniCap Cooling System to reduce hair loss during chemotherapy to include all patients with solid tumors.